Cardiogenic shock due to citomegalovirus myocarditis: Successful clinical treatment;Choque cardiogênico devido à miocardite por citomegalovírus: Terapêutica clínica com sucesso

Brazilian Journal of Cardiovascular Surgery

Volumn 25, Issue 2, 2010, Pages 149-153

  Baumgratz, José Francisco ^a   Vila, José Henrique Andrade ^a   da Silva, José Pedro ^a   da Fonseca, Luciana ^a   Rodrigues, Edwal A Campos ^a   Knobel, Elias ^a  

^a NONE

Author keywords

Cardiogenic shock; Ganciclovir; Myocarditis; Pulse therapy, drug

Indexed keywords

ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; GANCICLOVIR; GLUCOCORTICOID; PREDNISONE; TEICOPLANIN;

ADULT; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CYTOMEGALOVIRUS INFECTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYOCARDITIS; VIROLOGY;

ADULT; ANTI-BACTERIAL AGENTS; ANTIHYPERTENSIVE AGENTS; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; GLUCOCORTICOIDS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MYOCARDITIS; PREDNISONE; SHOCK, CARDIOGENIC; TEICOPLANIN;

EID: 79958797920     PISSN: 01027638     EISSN: 16789741     Source Type: Journal    
DOI: 10.1590/S0102-76382010000200004     Document Type: Article

References (20)

1. Olinde KD, O'Connell JB. Inflamatory heart disease: pathogenesis, clinical manifestations, and treatments of myocarditis. Ann Rev Med. 1994;45:481-90.
2. Davies MJ, Ward DE. How can myocarditis be diagnosed and should it be treated? Br Heart J. 1992;68(4):346-7.
3. Dec GW Jr, Waldman H, Southern J, Fallon JT, Hutter AM Jr, Palacios I. Viral myocarditis mimicking acute myocardial infarction. J Am Coll Cardiol. 1992;20(1):85-9.
4. Maisch B, Schönian U, Crombach M, Wendl I, Bethge C, Herzum M, et al. Cytomegalovirus associated inflammatory heart muscle disease. Scand J Infect Dis Suppl. 1993;88:135-48.
5. Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, et al. A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N Engl J Med. 1995;333(5):269-75.
6. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: two-year followup results. Circulation. 2001;104(1):39-45.
7. Bonkowsky HL, Lee RV, Klatskin G. Acute granulomatous hepatitis. Occurence in cytomegalovirus mononucleosis. JAMA. 1975;233(12):1284-8.
8. Horwitz CA, Henle W, Henle G, Snover D, Rudnick H, Balfour HH Jr, et al. Clinical and laboratory evaluation of cytomegalovirus-induced mononucleosis in previously healthy individuals. Report of 82 cases. Medicine (Baltimore). 1986;65(2):124-34.
9. Campbell PT, Li JS, Wall TC, O'Connor CM, Van Trigt P, Kenney RT, et al. Cytomegalovirus pericarditis: a case series and review of the literature. Am J Med Sci. 1995;309(4):229-34.
10. Zubiaurre L, Zapata E, Bujanda L, Castillo M, Oyarzabal I, Gutiérrez-Stampa MA, et al. Cytomegalovirus hepatitis and myopericarditis. World J Gastroenterol. 2007;13(4):647-8.
11. Dehtiar N, Eherlichman M, Picard E, Kleid D, Glaser J, Raveh D, et al. Cytomegalovirus myocarditis in a healthy infant: complete recovery after ganciclovir treatment. Pediatr Crit Care Med. 2001;2(3):271-3.
12. Ng TT, Morris DJ, Wilkins EG. Successful diagnosis and management of cytomegalovirus carditis. J Infect. 1997;34(3):243-7.
13. Dettmeyer R, Sperhake JP, Müller J, Madea B. Cytomegalovirus-induced pneumonia and myocarditis in three cases of suspected sudden infant death syndrome (SIDS): diagnosis by immunohistochemical techniques and molecularpathologic methods. Forensic Sci Int. 2008;174(2-3):229-33.
14. Kytö V, Vuorinen T, Saukko P, Lautenschlager I, Lignitz E, Saraste A, et al. Cytomegalovirus infection of the heart is common in patients with fatal myocarditis. Clin Infect Dis. 2005;40(5):683-8.
15. Pirilä L, Söderström KO, Hietarinta M, Jalava J, Kytö V, Toivanen A. Fatal myocardial necrosis caused by Staphylococcus lugdunensis and cytomegalovirus in a patient with scleroderma. J Clin Microbiol. 2006;44(6):2295-7.
16. Maisch B, Schönian U, Crombach M, Wendl I, Bethge C, Herzum M, et al. Cytomegalovirus associated inflammatory heart muscle disease. Scand J Infect Dis Suppl. 1993;88:135-48.
17. Sekiguchi A, Kashiwagi T, Ishida-Yamamoto A, Takahashi H, Hashimoto Y, Kimura H, et al. Drug-induced hypersensitivity syndrome due to mexiletine associated with human herpes virus 6 and cytomegalovirus reactivation. J Dermatol. 2005;32(4):278-81.
18. Figulla HR. Transformation of myocarditis and inflammatory cardiomyopathy to idiopathic dilated cardiomyopathy: facts and fiction. Med Microbiol Immunol. 2004;193(2-3):61-4.
19. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, et al. Underlying causes and long-term survival in the patients with initially unexplained cardiomyopathy. N Engl J Med. 2000;342(15):1077-84.
20. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al: ACC-AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005;112(12):e154-235.